Form 4: Arcellx CFO Michelle Gilson Sells Shares Under 10b5-1 Plan

Arcellx's Chief Financial Officer, Michelle Gilson, executed multiple sales of company stock under a pre-arranged 10b5-1 trading plan, along with sales to cover tax obligations related to vesting restricted stock units.

Summary

• Michelle Gilson, the Chief Financial Officer of Arcellx, Inc., sold a total of 17,910 shares of common stock between January 7th and January 8th, 2025.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan, which was initially established on December 18, 2023, and later modified on March 27, 2024.
• The sales occurred at various weighted average prices, ranging from $73.6929 to $77.0605 per share.
• Additionally, 15,339 shares were sold on January 3rd, 2025, to cover tax obligations related to the vesting of restricted stock units.
• The CFO also acquired 15,339 shares through the vesting of restricted stock units on January 3rd, 2025.

Sentiment

Score: 5

Explanation: The document reflects routine transactions under a pre-arranged trading plan, with no indication of positive or negative sentiment.

Risks

• The CFO's stock sales, while under a pre-arranged plan, could be interpreted negatively by some investors.

Industry Context

This is a routine filing for a corporate officer selling shares under a pre-arranged trading plan, which is common practice in publicly traded companies.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice for corporate insiders to avoid accusations of insider trading.
• The reported sales are consistent with typical executive compensation practices involving restricted stock units and tax obligations.

Stakeholder Impact

• The stock sales could have a minor impact on the share price, but the pre-arranged nature of the sales should mitigate any significant negative reaction.

Key Dates

Keywords

Arcellx, Michelle Gilson, SEC Form 4, stock sale, 10b5-1 plan, insider trading, restricted stock units, CFO, ACLX